← Leaderboards

William Robert Jacobs

Albert Einstein College Of Medicine

Google Scholar ↗PubMed ↗ORCID ↗

$47,063,631

Attributed

$51,385,861

Total exposure

25

Grants

21

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $5M · FY2005–25

$5M$3.8M$2.5M$1.3M$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$67,095,002 · 26

By mechanism

R01$26,196,215 · 7

P01$21,458,660 · 8

R37$6,942,997 · 1

R24$4,989,368 · 1

RC4$3,994,132 · 1

R21$2,863,800 · 6

Top collaborators

Most similar at Albert Einstein College Of Medicine

Same institution · by research overlap

Jonathan R. Lai$23,560,080

Others in their field

Top investigators on “Mycobacterium Tuberculosis”

Margaret Juliana McElrath · Fred Hutchinson Cancer Center$267,251,837
Constance Ann Benson · University Of California, San Diego$150,079,712
Kevin Urdahl · Seattle Children'S Hospital$86,597,961
David Alland · Rutgers Biomedical And Health Sciences$70,943,567
Sarah Fortune · Harvard School Of Public Health$51,119,645
Robert Turner Schooley · University Of Colorado Denver$42,307,156

Research focus

Mycobacterium TuberculosisTuberculosisGenesVaccinesInfectionGeneticBaseCellsPharmaceutical PreparationsMutantPhenotypeMediatingChemotherapyEpidemicPreventGrowthGlobal HealthImmune ResponseDrug ResistanceMacrophageMolecular GeneticsExtreme Drug Resistant TuberculosisMycobacterium SmegmatisMouse Model

Grant awards (117)

Esx5 secretome in TB and TB-HIV pathogenesis and immunity$820,246

R01 · FY2025 · AI · contact PI

Molecular Genetic Analysis of Mycobacterium Tuberculosis$778,383

R37 · FY2025 · AI · contact PI

Generation of a Complete Set of Precise Null Bar-Coded Deletion Mutants of Mycobacterium tuberculosis$645,418

R24 · FY2025 · AI · contact PI

Molecular Genetic Analysis of Mycobacterium Tuberculosis$786,783

R37 · FY2024 · AI · contact PI

Generation of a Complete Set of Precise Null Bar-Coded Deletion Mutants of Mycobacterium tuberculosis$729,283

R24 · FY2024 · AI · contact PI

Nanoluciferase reporter phage for rapid phenotypic characterization of resistance to next-generation antimycobacterial agents$179,286

R21 · FY2024 · AI

Molecular Genetic Analysis of Mycobacterium Tuberculosis$803,583

R37 · FY2023 · AI · contact PI

Generation of a Complete Set of Precise Null Bar-Coded Deletion Mutants of Mycobacterium tuberculosis$764,494

R24 · FY2023 · AI · contact PI

Nanoluciferase reporter phage for rapid phenotypic characterization of resistance to next-generation antimycobacterial agents$241,715

R21 · FY2023 · AI

Genetic engineering of Mycobacterium leprae to Glow and Grow$210,000

R21 · FY2023 · AI · contact PI

Molecular Genetic Analysis of Mycobacterium Tuberculosis$691,699

R01 · FY2022 · AI · contact PI

Genetic engineering of Mycobacterium leprae to Glow and Grow$252,000

R21 · FY2022 · AI · contact PI

TB Phage therapy: Optimizing delivery methods of mycobacteriophages to target intracellular Mycobacterium tuberculosis$210,000

R21 · FY2022 · AI · contact PI

Molecular Genetic Analysis of Mycobacterium Tuberculosis$691,756

R01 · FY2021 · AI · contact PI

Generation of a Complete Set of Precise Null Bar-Coded Deletion Mutants of Mycobacterium tuberculosis$572,071

R24 · FY2021 · AI · contact PI

TB Phage therapy: Optimizing delivery methods of mycobacteriophages to target intracellular Mycobacterium tuberculosis$251,938

R21 · FY2021 · AI · contact PI

Molecular Genetic Analysis of Mycobacterium Tuberculosis$691,684

R01 · FY2020 · AI · contact PI

Generation of a Complete Set of Precise Null Bar-Coded Deletion Mutants of Mycobacterium tuberculosis$572,071

R24 · FY2020 · AI · contact PI

Attenuated HSV Vaccines That Induce Protective Mucosal Antibodies$778,075

R01 · FY2019 · AI · contact PI

Molecular Genetic Analysis of Mycobacterium Tuberculosis$691,610

R01 · FY2019 · AI · contact PI

Generation of a Complete Set of Precise Null Bar-Coded Deletion Mutants of Mycobacterium tuberculosis$572,071

R24 · FY2019 · AI · contact PI

Shortening Tuberculosis Chemotherapies using N-acetylcysteine$250,500

R21 · FY2019 · AI · contact PI

Attenuated HSV Vaccines That Induce Protective Mucosal Antibodies$718,769

R01 · FY2018 · AI · contact PI

Attenuated HSV Vaccines That Induce Protective Mucosal Antibodies$460,950

R01 · FY2018 · AI · contact PI

Generation of a Complete Set of Precise Null Bar-Coded Deletion Mutants of Mycobacterium tuberculosis$428,706

R24 · FY2018 · AI · contact PI

Molecular Genetic Analysis of Mycobacterium tuberculosis$383,996

R01 · FY2018 · AI · contact PI

Molecular Genetic Analysis of Mycobacterium tuberculosis$192,346

R01 · FY2018 · AI · contact PI

Generation of a Complete Set of Precise Null Bar-Coded Deletion Mutants of Mycobacterium tuberculosis$143,365

R24 · FY2018 · AI · contact PI

Shortening Tuberculosis Chemotherapies using N-acetylcysteine$115,965

R21 · FY2018 · AI · contact PI

Shortening Tuberculosis Chemotherapies using N-acetylcysteine$92,785

R21 · FY2018 · AI · contact PI

Attenuated HSV Vaccines That Induce Protective Mucosal Antibodies$773,296

R01 · FY2017 · AI · contact PI

Molecular Genetic Analysis of Mycobacterium tuberculosis$576,342

R01 · FY2017 · AI · contact PI

Generation of a Complete Set of Precise Null Bar-Coded Deletion Mutants of Mycobacterium tuberculosis$561,889

R24 · FY2017 · AI · contact PI

Vaccines for Extensively Drug Resistant Tuberculosis$1,111,872

R01 · FY2016 · AI · contact PI

Attenuated HSV Vaccines That Induce Protective Mucosal Antibodies$791,681

R01 · FY2016 · AI · contact PI

Drugs targeting persistent Mycobacterium Tuberculosis$631,455

R01 · FY2016 · AI · contact PI

Molecular Genetic Analysis of Mycobacterium tuberculosis$576,342

R01 · FY2016 · AI · contact PI

Molecular Analysis of Tuberculosis Immunity$1,580,467

P01 · FY2015 · AI · contact PI

Vaccines for Extensively Drug Resistant Tuberculosis$741,248

R01 · FY2015 · AI · contact PI

Molecular Genetic Analysis of Mycobacterium tuberculosis$408,517

R01 · FY2015 · AI · contact PI

Drugs targeting persistent Mycobacterium Tuberculosis$386,358

R01 · FY2015 · AI · contact PI

"Genetic Approaches for Improving Tuberculosis Vaccines"$385,499

P01 · FY2015 · AI · contact PI

Vaccines for Extensively Drug Resistant Tuberculosis$370,624

R01 · FY2015 · AI · contact PI

Molecular Analysis of Tuberculosis Immunity$316,093

P01 · FY2015 · AI · contact PI

Drugs targeting persistent Mycobacterium Tuberculosis$259,755

R01 · FY2015 · AI · contact PI

Molecular Genetic Analysis of Mycobacterium tuberculosis$167,825

R01 · FY2015 · AI · contact PI

Program/Project Administrative$104,367

P01 · FY2015 · AI · contact PI

"Genetic Approaches for Improving Tuberculosis Vaccines"$77,101

P01 · FY2015 · AI · contact PI

Program/Project Administrative$20,873

P01 · FY2015 · AI · contact PI

Molecular Analysis of Tuberculosis Immunity$1,757,043

P01 · FY2014 · AI · contact PI

Vaccines for Extensively Drug Resistant Tuberculosis$1,111,872

R01 · FY2014 · AI · contact PI

Molecular Genetic Analysis of Mycobacterium tuberculosis$724,867

R01 · FY2014 · AI · contact PI

Drugs targeting persistent Mycobacterium Tuberculosis$665,659

R01 · FY2014 · AI · contact PI

"Genetic Approaches for Improving Tuberculosis Vaccines"$469,442

P01 · FY2014 · AI · contact PI

Molecular Analysis of Tuberculosis Immunity$129,111

P01 · FY2014 · AI · contact PI

Program/Project Administrative$125,239

P01 · FY2014 · AI · contact PI

Molecular Analysis of Tuberculosis Immunity$1,651,620

P01 · FY2013 · AI · contact PI

Vaccines for Extensively Drug Resistant Tuberculosis$1,045,159

R01 · FY2013 · AI · contact PI

Drugs targeting persistent Mycobacterium Tuberculosis$689,918

R01 · FY2013 · AI · contact PI

Reporter Phages for Diagnosis of Drug-Resistant TB in HIV High-Burden Populations$514,104

R56 · FY2013 · AI · contact PI

Molecular Genetic Analysis of Mycobacterium tuberculosis$477,409

R37 · FY2013 · AI · contact PI

"Genetic Approaches for Improving Tuberculosis Vaccines"$416,291

P01 · FY2013 · AI · contact PI

Program/Project Administrative$135,688

P01 · FY2013 · AI · contact PI

Molecular Analysis of Tuberculosis Immunity$1,757,042

P01 · FY2012 · AI · contact PI

Vaccines for Extensively Drug Resistant Tuberculosis$1,427,671

R01 · FY2012 · AI · contact PI

Molecular Genetic Analysis of Mycobacterium tuberculosis$507,880

R37 · FY2012 · AI · contact PI

"Genetic Approaches for Improving Tuberculosis Vaccines"$437,327

P01 · FY2012 · AI · contact PI

Program/Project Administrative$142,828

P01 · FY2012 · AI · contact PI

Molecular Analysis of Tuberculosis Immunity$1,760,691

P01 · FY2011 · AI · contact PI

Molecular Genetic Analysis of Mycobacterium tuberculosis$508,081

R37 · FY2011 · AI · contact PI

"Genetic Approaches for Improving Tuberculosis Vaccines"$380,669

P01 · FY2011 · AI · contact PI

Program/Project Administrative$202,893

P01 · FY2011 · AI · contact PI

Metabolomic Analysis of Redox control in Mycobacterium tuberculosis persisters$177,656

R21 · FY2011 · AI · contact PI

High throughput Genetic Analysis of Mycobacterium tuberculosis$3,994,132

RC4 · FY2010 · AI · contact PI

Molecular Genetic Analysis of Mycobacterium tuberculosis$513,196

R37 · FY2010 · AI · contact PI

Metabolomic Analysis of Redox control in Mycobacterium tuberculosis persisters$249,000

R21 · FY2010 · AI · contact PI

Molecular Analysis of Tuberculosis Immunity$1,442,274

P01 · FY2009 · AI · contact PI

Molecular Genetic Analysis of Mycobacterium tuberculosis$503,279

R37 · FY2009 · AI · contact PI

Genetic Approaches for Improving Tuberculosis Vaccines$316,623

P01 · FY2009 · AI · contact PI

Administrative Core$137,320

P01 · FY2009 · AI · contact PI

Molecular Analysis of Tuberculosis Immunity$1,401,616

P01 · FY2008 · AI · contact PI

INH-induced lysis of the HIV opportunistic infection, M. tuberculosis$627,577

R01 · FY2008 · AI · contact PI

Molecular Genetic Analysis of Mycobacterium tuberculosis$419,399

R37 · FY2008 · AI · contact PI

Genetic Approaches for Improving Tuberculosis Vaccines$315,517

P01 · FY2008 · AI · contact PI

MODEL SYSTEMS TO STUDY FAS-II INHIBITORS$173,707

P01 · FY2008 · AI · contact PI

Administrative Core$134,175

P01 · FY2008 · AI · contact PI

Molecular Analysis of Tuberculosis Immunity$1,388,602

P01 · FY2007 · AI · contact PI

INH-induced lysis of the HIV opportunistic infection, M. tuberculosis$621,100

R01 · FY2007 · AI · contact PI

Molecular Genetic Analysis of Mycobacterium tuberculosis$415,237

R37 · FY2007 · AI · contact PI

Genetic Approaches for Improving Tuberculosis Vaccines$344,752

P01 · FY2007 · AI · contact PI

MODEL SYSTEMS TO STUDY FAS-II INHIBITORS$177,067

P01 · FY2007 · AI · contact PI

Molecular Analysis of Tuberculosis Immunity$1,399,546

P01 · FY2006 · AI · contact PI

INH-induced lysis of the HIV OI, M. tuberculosis$621,016

R01 · FY2006 · AI · contact PI

Molecular Genetic Analysis of Mycobacterium tuberculosis$415,354

R37 · FY2006 · AI · contact PI

Genetic Approaches for Improving Tuberculosis Vaccines$320,602

P01 · FY2006 · AI · contact PI

MODEL SYSTEMS TO STUDY FAS-II INHIBITORS$186,742

P01 · FY2006 · AI · contact PI

Molecular Analysis of Tuberculosis Immunity$1,125,036

P01 · FY2005 · AI

INH-induced lysis of the HIV OI, M. tuberculosis$617,440

R01 · FY2005 · AI

Molecular Genetic Analysis of Mycobacterium tuberculosis$413,135

R37 · FY2005 · AI

Genetic Approaches for Improving Tuberculosis Vaccines$249,113

P01 · FY2005 · AI

MODEL SYSTEMS TO STUDY FAS-II INHIBITORS$186,742

P01 · FY2005 · AI

Administrative Core$122,378

P01 · FY2005 · AI

INH-induced lysis of the HIV OI, M. tuberculosis$479,960

R01 · FY2004 · AI

Molecular Genetic Analysis of Mycobacterium tuberculosis$401,278

R37 · FY2004 · AI

MODEL SYSTEMS TO STUDY FAS-II INHIBITORS$186,564

P01 · FY2004 · AI

INH-induced lysis of Mycobacterium tuberculosis$632,955

R21 · FY2003 · AI

MOLECULAR GENETIC ANALYSIS OF MYCOBACTERIUM TUBERCULOSIS$336,402

R01 · FY2003 · AI

INHIBITION OF MYOCOLIC ACID BIOSYNTHESIS--M.TUBERCULOSIS$776,978

R01 · FY2002 · AI

MOLECULAR GENETIC ANALYSIS OF MYCOBACTERIUM TUBERCULOSIS$326,605

R01 · FY2002 · AI

INHIBITION OF MYOCOLIC ACID BIOSYNTHESIS--M.TUBERCULOSIS$754,349

R01 · FY2001 · AI

RECOMBINANT BCG MALARIA VACCINES$531,893

R01 · FY2001 · AI

MOLECULAR GENETIC ANALYSIS OF MYCOBACTERIUM TUBERCULOSIS$317,090

R01 · FY2001 · AI

INHIBITION OF MYOCOLIC ACID BIOSYNTHESIS--M.TUBERCULOSIS$732,377

R01 · FY2000 · AI

RECOMBINANT BCG MALARIA VACCINES$539,499

R01 · FY2000 · AI

MOLECULAR GENETIC ANALYSIS OF MYCOBACTERIUM TUBERCULOSIS$307,858

R01 · FY2000 · AI

REAL-TIME PCR WITH MOLECULAR BEACONS$135,726

S10 · FY2000 · RR

RECOMBINANT BCG MALARIA VACCINES$24,479

R01 · FY2000 · AI